Longevity of patients with cystic fibrosis in 2000 to 2010 and beyond: Survival analysis of the Cystic Fibrosis Foundation Patient Registry

Annals of Internal Medicine

Volumn 161, Issue 4, 2014, Pages 233-241

  MacKenzie, Todd ^a   Gifford, Alex H ^a   Sabadosa, Kathryn A ^b   Quinton, Hebe B ^a   Knapp, Emily A ^c   Goss, Christopher H ^d   Marshall, Bruce C ^c  

^a DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^b DARTMOUTH INSTITUTE FOR HEALTH POLICY AND CLINICAL PRACTICE   (United States)

^c CYSTIC FIBROSIS FOUNDATION   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CYSTIC FIBROSIS; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; LONGEVITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; MUTATION; PRIORITY JOURNAL; REGISTER; SEX DIFFERENCE; SURVIVAL; UNITED STATES; CHILD; EPIDEMIOLOGY; ETHNOLOGY; GENETICS; INFANT; NEWBORN; ONSET AGE; PRESCHOOL CHILD; PROGNOSIS; YOUNG ADULT;

CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR DELTA F508;

ADOLESCENT; ADULT; AGE OF ONSET; CHILD; CHILD, PRESCHOOL; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; LONGEVITY; MALE; MUTATION; PROGNOSIS; REGISTRIES; SEX FACTORS; SURVIVAL ANALYSIS; UNITED STATES; YOUNG ADULT;

EID: 84907343152     PISSN: 00034819     EISSN: 15393704     Source Type: Journal    
DOI: 10.7326/M13-0636     Document Type: Article

References (54)

1. Cystic Fibrosis Foundation. About Cystic Fibrosis. Bethesda, MD: Cystic Fibrosis Foundation; 2012. Accessed at www.cff.org/AboutCF on 12 December 2012.
2. FitzSimmons SC. The changing epidemiology of cystic fibrosis. J Pediatr. 1993;122:1-9. [PMID: 8419592]
3. Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, et al. Survival effect of lung transplantation among patients with cystic fibrosis. JAMA. 2001;286:2683-9. [PMID: 11730443]
4. Mayer-Hamblett N, Rosenfeld M, Emerson J, Goss CH, Aitken ML. Developing cystic fibrosis lung transplant referral criteria using predictors of 2-year mortality. Am J Respir Crit Care Med. 2002;166:1550-5. [PMID: 12406843]
5. Dasenbrook EC, Checkley W, Merlo CA, Konstan MW, Lechtzin N, Boyle MP. Association between respiratory tract methicillin-resistant Staphylococcus aureus and survival in cystic fibrosis. JAMA. 2010;303:2386-92. [PMID: 20551409]
6. Andersen DH. Cystic fibrosis of the pancreas. J Chronic Dis. 1958;7:58-90. [PMID: 13491678]
7. Cystic Fibrosis Foundation. Cystic Fibrosis Patient Registry. Bethesda, MD: Cystic Fibrosis Foundation; 2012. Accessed at www.cff.org/UploadedFiles/ research/ClinicalResearch/PatientRegistryReport/2012-CFF-Patient-Registry.pdf on 12 December 2012.
8. Flume PA, O'Sullivan BP, Robinson KA, Goss CH, Mogayzel PJ Jr, Willey- Courand DB, et al; Cystic Fibrosis Foundation, Pulmonary Therapies Committee. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176:957-69. [PMID: 17761616]
9. Stallings VA, Stark LJ, Robinson KA, Feranchak AP, Quinton H; Clinical Practice Guidelines on Growth and Nutrition Subcommittee. Evidence-based practice recommendations for nutrition-related management of children and adults with cystic fibrosis and pancreatic insufficiency: results of a systematic review. J Am Diet Assoc. 2008;108:832-9. [PMID: 18442507]
10. Moran A, Brunzell C, Cohen RC, Katz M, Marshall BC, Onady G, et al; CFRD Guidelines Committee. Clinical care guidelines for cystic fibrosis-related diabetes: a position statement of the American Diabetes Association and a clinical practice guideline of the Cystic Fibrosis Foundation, endorsed by the Pediatric Endocrine Society. Diabetes Care. 2010;33:2697-708. [PMID: 21115772]
11. Marshall BC, Campbell PW 3rd. Improving the care of infants identified through cystic fibrosis newborn screening. J Pediatr. 2009;155:S71-2. [PMID: 19914444]
12. Cystic Fibrosis Foundation. Cystic Fibrosis Patient Registry Annual Data Report 2010. Bethesda, MD: Cystic Fibrosis Foundation; 2010.
13. Andersson-Segesten K, Plos K. The needs, concerns and coping of mothers of children with cystic fibrosis. Scand J Caring Sci. 1989;3:35-41. [PMID: 2740666]
14. Sueblinvong V, Whittaker LA. Fertility and pregnancy: common concerns of the aging cystic fibrosis population. Clin Chest Med. 2007;28:433-43. [PMID: 17467558]
15. Iles N, Lowton K. What is the perceived nature of parental care and support for young people with cystic fibrosis as they enter adult health services? Health Soc Care Community. 2010;18:21-9. [PMID: 19637994]
16. Nick JA, Chacon CS, Brayshaw SJ, Jones MC, Barboa CM, St Clair CG, et al. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis. Am J Respir Crit Care Med. 2010;182:614-26. [PMID: 20448091]
17. Jackson AD, Daly L, Kelleher C, Marshall BC, Quinton HB, Foley L, et al. The application of current lifetable methods to compare cystic fibrosis median survival internationally is limited. J Cyst Fibros. 2011;10:62-5. [PMID: 20888308]
18. O'Donnell EP, Scarsi KK, Scheetz MH, Postelnick MJ, Cullina J, Jain M. Risk factors for aminoglycoside ototoxicity in adult cystic fibrosis patients [Letter]. Int J Antimicrob Agents. 2010;36:94-5. [PMID: 20382508]
19. Al-Aloul M, Miller H, Alapati S, Stockton PA, Ledson MJ, Walshaw MJ. Renal impairment in cystic fibrosis patients due to repeated intravenous aminoglycoside use. Pediatr Pulmonol. 2005;39:15-20. [PMID: 15521084]
20. Schwarzenberg SJ, Thomas W, Olsen TW, Grover T, Walk D, Milla C, et al. Microvascular complications in cystic fibrosis-related diabetes. Diabetes Care. 2007;30:1056-61. [PMID: 17322485]
21. Quittner AL, Barker DH, Snell C, Grimley ME, Marciel K, Cruz I. Prevalence and impact of depression in cystic fibrosis. Curr Opin Pulm Med. 2008; 14:582-8. [PMID: 18812836]
22. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J. 2007;29:522-6. [PMID: 17182652]
23. Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr. 2008;153:S4-S14. [PMID: 18639722]
24. Kulich M, Rosenfeld M, Goss CH, Wilmott R. Improved survival among young patients with cystic fibrosis. J Pediatr. 2003;142:631-6. [PMID: 12838190]
25. O'Connor GT, Quinton HB, Kahn R, Robichaud P, Maddock J, Lever T, et al; Northern New England Cystic Fibrosis Consortium. Case-mix adjustment for evaluation of mortality in cystic fibrosis. Pediatr Pulmonol. 2002;33:99-105. [PMID: 11802245]
26. McKone EF, Emerson SS, Edwards KL, Aitken ML. Effect of genotype on phenotype and mortality in cystic fibrosis: a retrospective cohort study. Lancet. 2003;361:1671-6. [PMID: 12767731]
27. Zielenski J, Tsui LC. Cystic fibrosis: genotypic and phenotypic variations. Annu Rev Genet. 1995;29:777-807. [PMID: 8825494]
28. Elborn JS, Shale DJ, Britton JR. Cystic fibrosis: current survival and population estimates to the year 2000. Thorax. 1991;46:881-5. [PMID: 1792634]
29. Jackson AD, Daly L, Jackson AL, Kelleher C, Marshall BC, Quinton HB, et al. Validation and use of a parametric model for projecting cystic fibrosis survivorship beyond observed data: a birth cohort analysis. Thorax. 2011;66: 674-9. [PMID: 21653925]
30. Schluchter MD, Konstan MW, Davis PB. Jointly modelling the relationship between survival and pulmonary function in cystic fibrosis patients. Stat Med. 2002;21:1271-87. [PMID: 12111878]
31. Emerson J, Rosenfeld M, McNamara S, Ramsey B, Gibson RL. Pseudomonas aeruginosa and other predictors of mortality and morbidity in young children with cystic fibrosis. Pediatr Pulmonol. 2002;34:91-100. [PMID: 12112774]
32. Konstan MW, Morgan WJ, Butler SM, Pasta DJ, Craib ML, Silva SJ, et al; Scientific Advisory Group and the Investigators and Coordinators of the Epidemiologic Study of Cystic Fibrosis. Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis. J Pediatr. 2007;151:134-9, 139.e1. [PMID: 17643762]
33. Modi AC, Marciel KK, Slater SK, Drotar D, Quittner AL. The influence of parental supervision on medical adherence in adolescents with cystic fibrosis: Developmental shifts from pre to late adolescence. Child Health Care. 2008;37: 78-92.
34. Rosenfeld M, Davis R, FitzSimmons S, Pepe M, Ramsey B. Gender gap in cystic fibrosis mortality. Am J Epidemiol. 1997;145:794-803. [PMID: 9143209]
35. Barr HL, Britton J, Smyth AR, Fogarty AW. Association between socioeconomic status, sex, and age at death from cystic fibrosis in England and Wales (1959 to 2008): cross sectional study. BMJ. 2011;343:d4662. [PMID: 21862532]
36. Abbott J, Dodd M, Bilton D, Webb AK. Treatment compliance in adults with cystic fibrosis. Thorax. 1994;49:115-20. [PMID: 8128399]
37. Fogarty AW, Britton J, Clayton A, Smyth AR. Are measures of body habitus associated with mortality in cystic fibrosis? Chest. 2012;142:712-7. [PMID: 22362875]
38. Coakley RD, Sun H, Clunes LA, Rasmussen JE, Stackhouse JR, Okada SF, et al. 17beta-Estradiol inhibits Ca2+dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia. J Clin Invest. 2008;118: 4025-35. [PMID: 19033671]
39. Zeitlin PL. Cystic fibrosis and estrogens: a perfect storm. J Clin Invest. 2008;118:3841-4. [PMID: 19033654]
40. Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH. Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med. 2011;184:1147-52. [PMID: 21799076]
41. Figueroa V, Milla C, Parks EJ, Schwarzenberg SJ, Moran A. Abnormal lipid concentrations in cystic fibrosis. Am J Clin Nutr. 2002;75:1005-11. [PMID: 12036806]
42. Hernandez-Jimenez I, Fischman D, Cheriyath P. Colon cancer in cystic fibrosis patients: is this a growing problem? J Cyst Fibros. 2008;7:343-6. [PMID: 18374636]
43. Riekert KA, Bartlett SJ, Boyle MP, Krishnan JA, Rand CS. The association between depression, lung function, and health-related quality of life among adults with cystic fibrosis. Chest. 2007;132:231-7. [PMID: 17625085]
44. Sawicki GS, Sellers DE, Robinson WM. High treatment burden in adults with cystic fibrosis: challenges to disease self-management. J Cyst Fibros. 2009; 8:91-6. [PMID: 18952504]
45. Schechter MS, Fink AK, Homa K, Goss CH. The Cystic Fibrosis Foundation Patient Registry as a tool for use in quality improvement. BMJ Qual Saf. 2014;23 Suppl 1:i9-14. [PMID: 24443584]
46. Sabadosa KA, Batalden PB. The interdependent roles of patients, families and professionals in cystic fibrosis: a system for the coproduction of healthcare and its improvement. BMJ Qual Saf. 2014;23 Suppl 1:i90-4. [PMID: 24608555]
47. Godfrey MM, Oliver BJ. Accelerating the rate of improvement in cystic fibrosis care: contributions and insights of the learning and leadership collaborative. BMJ Qual Saf. 2014;23 Suppl 1:i23-i32. [PMID: 24608547]
48. Okumura MJ, Ong T, Dawson D, Nielson D, Lewis N, Richards M, et al. Improving transition from paediatric to adult cystic fibrosis care: programme implementation and evaluation. BMJ Qual Saf. 2014;23 Suppl 1:i64-i72. [PMID: 24415776]
49. Rayas MS, Willey-Courand DB, Lynch JL, Guajardo JR. Improved screening for cystic fibrosis-related diabetes by an integrated care team using an algorithm. Pediatr Pulmonol. 16 Jan 2014. [Epub ahead of print] [PMID: 24436252]
50. Gilljam M, Ellis L, Corey M, Zielenski J, Durie P, Tullis DE. Clinical manifestations of cystic fibrosis among patients with diagnosis in adulthood. Chest. 2004;126:1215-24. [PMID: 15486385]
51. Therneau TM. A Package for Survival Analysis in S. R package version 2.37-7. Accessed at http://CRAN.R-project.org/package=survival on 4 June 2014.
52. Wand MP, Jones MC. Kernel Smoothing. 1st ed. New York: Chapman & Hall; 1995.
53. Klein JP, Lee SC, Moeschberger ML. A partially parametric estimator of survival in the presence of randomly censored data. Biometrics. 1990;46:795-811. [PMID: 2242415]
54. Moeschberger ML, Klein JP. A comparison of several methods of estimating the survival function when there is extreme right censoring. Biometrics. 1985;41: 253-9. [PMID: 4005379]